Ronal Legako
Family Medicine · Edmond, OKNPI 1356318919
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,694 and has fallen 99.5% since, to $14 in 2023.
Across 214 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$746
- Biohaven Pharmaceutical Holding Company Ltd.$497
- GSK$389
- Amarin Pharma, Inc.$327
- Boehringer Ingelheim$288
- Lilly USA, LLC$226
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,507100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 34 | $746 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $497 |
| GSK | 17 | $389 |
| Amarin Pharma, Inc. | 12 | $327 |
| Boehringer Ingelheim | 16 | $288 |
| Lilly USA, LLC | 21 | $226 |
| Pfizer | 8 | $210 |
| Genentech USA, Inc. | 7 | $206 |
| Abbott | 6 | $202 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $175 |
| Merck | 13 | $173 |
| Novo Nordisk | 5 | $166 |
| Sanofi-aventis U.S. LLC | 5 | $153 |
| Novartis | 7 | $110 |
| Antares Pharma, Inc. | 6 | $97 |
| Otsuka America Pharmaceutical, Inc. | 5 | $84 |
| Astellas Pharma US Inc | 4 | $69 |
| Dynavax Technologies Corporation | 4 | $57 |
| Althera Pharmaceuticals LLC | 4 | $56 |
| Amgen | 4 | $48 |
| Johnson & Johnson | 2 | $39 |
| Upsher-smith Laboratories LLC | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $27 |
| Sanofi Pasteur Inc. | 2 | $25 |
| Therapeuticsmd, Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Inogen, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$353
- VRAYLAR$220
- Vascepa$125
- Xofluza$124
- SHINGRIX$123
- Xience Sierra Coronary Stent$121
- Ozempic$120
How this compares
$4,513 in reported general payments places this provider in the 85th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Edmond
- Stanley ShadidEdmond$363K
- Susan DimickEdmond$28K
- Charles WoodwardEdmond$15K
- Darrel StoutEdmond$13K
- Christopher HayesEdmond$13K
- Jerimiah JohnsonEdmond$12K
- Alexander FrankOklahoma City$3.1M
- Geoffrey PlumleeTulsa$297K
- Curtis HarrisAda$125K
- Melinda CailOklahoma City$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.